Cargando…
Clinical impact of stress dose steroids in patients with septic shock: insights from the PROWESS-Shock trial
INTRODUCTION: The aim of our study was to evaluate the clinical impact of the administration of intravenous steroids, alone or in conjunction with drotrecogin-alfa (activated) (DrotAA), on the outcomes in septic shock patients. METHODS: We performed a sub-study of the PROWESS-Shock trial (septic sho...
Autores principales: | Póvoa, Pedro, Salluh, Jorge I F, Martinez, Maria L, Guillamat-Prats, Raquel, Gallup, Dianne, Al-Khalidi, Hussein R, Thompson, B Taylor, Ranieri, V Marco, Artigas, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456711/ https://www.ncbi.nlm.nih.gov/pubmed/25928214 http://dx.doi.org/10.1186/s13054-015-0921-x |
Ejemplares similares
-
Statistical analysis plan of PROWESS SHOCK study
por: Thompson, B. Taylor, et al.
Publicado: (2010) -
Severe sepsis: are PROWESS and PROWESS-SHOCK trials comparable? A clinical and statistical heterogeneity analysis
por: Kalil, Andre C, et al.
Publicado: (2013) -
Methotrexate Ameliorates Systemic Inflammation and Septic Associated-Lung Damage in a Cecal Ligation and Puncture Septic Rat Model
por: Bringué, Josep, et al.
Publicado: (2021) -
Septic shock: the changing Zeitgeist of management
por: Cheng, Allen C, et al.
Publicado: (2009) -
Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated)
por: Levy, Howard, et al.
Publicado: (2005)